Registering randomized clinical trials and the case for CONSORT.
- 1 January 2007
- journal article
- review article
- Published by American Psychological Association (APA) in Experimental and Clinical Psychopharmacology
- Vol. 15 (6), 511-518
- https://doi.org/10.1037/1064-1297.15.6.511
Abstract
Recent controversies in medical research and the increasing reliance on randomized clinical trials to inform evidence-based practice have prompted coordinated attempts to standardize reporting and register information about trials for consistency and transparency. The Consolidated Standards of Reporting Trials guidelines (D. G. Altman et al., 2001) and trial registry are described in this article, and the implications for clinical and experimental research in psychopharmacology are discussed.Keywords
Funding Information
- National Institute on Disability and Rehabilitation Research (H133N5009; H133B980016A)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32 HD07420)
- Centers for Disease Control and Prevention (R49/CE000191)
This publication has 21 references indexed in Scilit:
- Reporting Implementation in Randomized Trials: Proposed Additions to the Consolidated Standards of Reporting Trials StatementAmerican Journal of Public Health, 2007
- Is This Clinical Trial Fully Registered?Annals of Internal Medicine, 2005
- Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT StatementAnnals of Internal Medicine, 2004
- Clinical Trial RegistrationJAMA, 2004
- Trial RegistrationJAMA, 2004
- Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished dataThe Lancet, 2004
- Editorial: New policy on reports of randomized clinical trialsAnnals of Behavioral Medicine, 2004
- Drug company experts advised staff to withhold data about SSRI use in childrenCMAJ : Canadian Medical Association Journal, 2004
- Evidence-based behavioral medicine: What is it and how do we achieve it?Annals of Behavioral Medicine, 2003
- Rules of evidence and clinical recommendations on the use of antithrombotic agents.1989